Completed NA INTERVENTIONAL 1-arm
NCT00736801
Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma
Sponsor: GlaxoSmithKline
Conditions
Allergic Asthma
Interventions
Salmeterol and Salmeterol / Fluticasone
Updated 5 times since 2017 Last updated: Aug 20, 2008 Started: Sep 30, 2005 Primary completion: Jan 31, 2007 Completion: Apr 30, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Allergic Asthma, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- GlaxoSmithKline
- University of Rostock
Data source: University of Rostock
For direct contact, visit the study record on ClinicalTrials.gov .